Literature DB >> 22542780

Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex.

Imran Bhutto1, Gerard Lutty.   

Abstract

There is a mutualistic symbiotic relationship between the components of the photoreceptor/retinal pigment epithelium (RPE)/Bruch's membrane (BrMb)/choriocapillaris (CC) complex that is lost in AMD. Which component in the photoreceptor/RPE/BrMb/CC complex is affected first appears to depend on the type of AMD. In atrophic AMD (~85-90% of cases), it appears that large confluent drusen formation and hyperpigmentation (presumably dysfunction in RPE) are the initial insult and the resorption of these drusen and loss of RPE (hypopigmentation) can be predictive for progression of geographic atrophy (GA). The death and dysfunction of photoreceptors and CC appear to be secondary events to loss in RPE. In neovascular AMD (~10-15% of cases), the loss of choroidal vasculature may be the initial insult to the complex. Loss of CC with an intact RPE monolayer in wet AMD has been observed. This may be due to reduction in blood supply because of large vessel stenosis. Furthermore, the environment of the CC, basement membrane and intercapillary septa, is a proinflammatory milieu with accumulation of complement components as well as proinflammatory molecules like CRP during AMD. In this toxic milieu, CC die or become dysfunction making adjacent RPE hypoxic. These hypoxic cells then produce angiogenic substances like VEGF that stimulate growth of new vessels from CC, resulting in choroidal neovascularization (CNV). The loss of CC might also be a stimulus for drusen formation since the disposal system for retinal debris and exocytosed material from RPE would be limited. Ultimately, the photoreceptors die of lack of nutrients, leakage of serum components from the neovascularization, and scar formation. Therefore, the mutualistic symbiotic relationship within the photoreceptor/RPE/BrMb/CC complex is lost in both forms of AMD. Loss of this functionally integrated relationship results in death and dysfunction of all of the components in the complex.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22542780      PMCID: PMC3392421          DOI: 10.1016/j.mam.2012.04.005

Source DB:  PubMed          Journal:  Mol Aspects Med        ISSN: 0098-2997


  214 in total

1.  Effect of aging on foveolar choroidal circulation.

Authors:  J E Grunwald; S M Hariprasad; J DuPont
Journal:  Arch Ophthalmol       Date:  1998-02

2.  A hemodynamic model of the pathogenesis of age-related macular degeneration.

Authors:  E Friedman
Journal:  Am J Ophthalmol       Date:  1997-11       Impact factor: 5.258

3.  Cultured human retinal pigment epithelial cells express basic fibroblast growth factor and its receptor.

Authors:  M D Sternfeld; J E Robertson; G D Shipley; J Tsai; J T Rosenbaum
Journal:  Curr Eye Res       Date:  1989-10       Impact factor: 2.424

4.  Systemic markers of inflammation, endothelial dysfunction, and age-related maculopathy.

Authors:  Ronald Klein; Barbara E K Klein; Michael D Knudtson; Tien Yin Wong; Anoop Shankar; Michael Y Tsai
Journal:  Am J Ophthalmol       Date:  2005-07       Impact factor: 5.258

5.  Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells.

Authors:  H Miyajima-Uchida; H Hayashi; R Beppu; M Kuroki; M Fukami; F Arakawa; Y Tomita; M Kuroki; K Oshima
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-02       Impact factor: 4.799

6.  Effects of hyperoxia on the oxygen distribution in the intact cat retina.

Authors:  R A Linsenmeier; C M Yancey
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-04       Impact factor: 4.799

Review 7.  Retinal oxygen: fundamental and clinical aspects.

Authors:  Norbert D Wangsa-Wirawan; Robert A Linsenmeier
Journal:  Arch Ophthalmol       Date:  2003-04

Review 8.  PEDF: anti-angiogenic guardian of ocular function.

Authors:  Noël Bouck
Journal:  Trends Mol Med       Date:  2002-07       Impact factor: 11.951

9.  Blockade of nitric-oxide synthase reduces choroidal neovascularization.

Authors:  Akira Ando; Amy Yang; Hiroyuki Nambu; Peter A Campochiaro
Journal:  Mol Pharmacol       Date:  2002-09       Impact factor: 4.436

10.  Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.

Authors:  L P Aiello; R L Avery; P G Arrigg; B A Keyt; H D Jampel; S T Shah; L R Pasquale; H Thieme; M A Iwamoto; J E Park
Journal:  N Engl J Med       Date:  1994-12-01       Impact factor: 91.245

View more
  323 in total

Review 1.  Enhanced depth imaging-OCT of the choroid: a review of the current literature.

Authors:  H Laviers; H Zambarakji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-04       Impact factor: 3.117

2.  Combined 60° Wide-Field Choroidal Thickness Maps and High-Definition En Face Vasculature Visualization Using Swept-Source Megahertz OCT at 1050 nm.

Authors:  Kathrin J Mohler; Wolfgang Draxinger; Thomas Klein; Jan Philip Kolb; Wolfgang Wieser; Christos Haritoglou; Anselm Kampik; James G Fujimoto; Aljoscha S Neubauer; Robert Huber; Armin Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

3.  Ultrahigh-Speed, Swept-Source Optical Coherence Tomography Angiography in Nonexudative Age-Related Macular Degeneration with Geographic Atrophy.

Authors:  WooJhon Choi; Eric M Moult; Nadia K Waheed; Mehreen Adhi; ByungKun Lee; Chen D Lu; Talisa E de Carlo; Vijaysekhar Jayaraman; Philip J Rosenfeld; Jay S Duker; James G Fujimoto
Journal:  Ophthalmology       Date:  2015-10-17       Impact factor: 12.079

Review 4.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

Review 5.  Metalloproteinases as mediators of inflammation and the eyes: molecular genetic underpinnings governing ocular pathophysiology.

Authors:  Mahavir Singh; Suresh C Tyagi
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

6.  Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.

Authors:  Lyndon da Cruz; Kate Fynes; Odysseas Georgiadis; Julie Kerby; Yvonne H Luo; Ahmad Ahmado; Amanda Vernon; Julie T Daniels; Britta Nommiste; Shazeen M Hasan; Sakina B Gooljar; Amanda-Jayne F Carr; Anthony Vugler; Conor M Ramsden; Magda Bictash; Mike Fenster; Juliette Steer; Tricia Harbinson; Anna Wilbrey; Adnan Tufail; Gang Feng; Mark Whitlock; Anthony G Robson; Graham E Holder; Mandeep S Sagoo; Peter T Loudon; Paul Whiting; Peter J Coffey
Journal:  Nat Biotechnol       Date:  2018-03-19       Impact factor: 54.908

7.  Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report.

Authors:  Paolo Giuseppe Limoli; Enzo Maria Vingolo; Celeste Limoli; Sergio Zaccaria Scalinci; Marcella Nebbioso
Journal:  J Vis Exp       Date:  2018-02-12       Impact factor: 1.355

8.  Deletion of hemojuvelin, an iron-regulatory protein, in mice results in abnormal angiogenesis and vasculogenesis in retina along with reactive gliosis.

Authors:  Amany Tawfik; Jaya P Gnana-Prakasam; Sylvia B Smith; Vadivel Ganapathy
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

Review 9.  The suprachoroidal space as a route of administration to the posterior segment of the eye.

Authors:  Bryce Chiang; Jae Hwan Jung; Mark R Prausnitz
Journal:  Adv Drug Deliv Rev       Date:  2018-03-12       Impact factor: 15.470

10.  Oxidative stress sensitizes retinal pigmented epithelial (RPE) cells to complement-mediated injury in a natural antibody-, lectin pathway-, and phospholipid epitope-dependent manner.

Authors:  Kusumam Joseph; Liudmila Kulik; Beth Coughlin; Kannan Kunchithapautham; Mausumi Bandyopadhyay; Steffen Thiel; Nicole M Thielens; V Michael Holers; Bärbel Rohrer
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.